China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Up 1,448.9% in February

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCGet Free Report) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 72,800 shares, an increase of 1,448.9% from the February 13th total of 4,700 shares. Approximately 3.2% of the shares of the company are sold short. Based on an average daily trading volume, of 183,400 shares, the short-interest ratio is currently 0.4 days.

China SXT Pharmaceuticals Price Performance

Shares of SXTC opened at $3.04 on Thursday. China SXT Pharmaceuticals has a 1 year low of $2.40 and a 1 year high of $26.96. The company’s fifty day moving average is $3.67 and its two-hundred day moving average is $4.06.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Read More

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.